WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H562671
CAS#: 770-05-8
Description: Octopamine HCl is an invertebrate biogenic amine neurotransmitter.
Hodoodo Cat#: H562671
Name: Octopamine HCl
CAS#: 770-05-8
Chemical Formula: C8H12ClNO2
Exact Mass: 189.06
Molecular Weight: 189.639
Elemental Analysis: C, 50.67; H, 6.38; Cl, 18.69; N, 7.39; O, 16.87
Synonym: Octopamine HCl; Octopamine HCl salt; Octopamine Hydrochloride; Octopamine Hydrochloride salt;
IUPAC/Chemical Name: 4-(2-Amino-1-hydroxyethyl)phenol hydrochloride
InChi Key: PUMZXCBVHLCWQG-UHFFFAOYSA-N
InChi Code: InChI=1S/C8H11NO2.ClH/c9-5-8(11)6-1-3-7(10)4-2-6;/h1-4,8,10-11H,5,9H2;1H
SMILES Code: OC1=CC=C(C(O)CN)C=C1.[H]Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 189.64 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Li LB, Cui XN, Reith MA. Is Na(+) required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter? Naunyn Schmiedebergs Arch Pharmacol. 2002 Apr;365(4):303-11. Epub 2002 Feb 20. PubMed PMID: 11919655.
2: Kirschbaum J, Rebscher K, Brückner H. Liquid chromatographic determination of biogenic amines in fermented foods after derivatization with 3,5-dinitrobenzoyl chloride. J Chromatogr A. 2000 Jun 9;881(1-2):517-30. PubMed PMID: 10905732.
3: Capasso A, Carginale V, Madonna L, Mancaniello D, Scudiero R, Paolo De Prisco P, De Petrocellis B, Parisi E. A dopamine- and octopamine-sensitive adenylate cyclase in the nervous system of Octopus vulgaris. Comp Biochem Physiol B. 1991;100(4):805-8. PubMed PMID: 1782763.
4: Baraldi M, Zeneroli ML, Ricci P, Caselgrandi E, Ventura E. Down regulation of striatal dopamine receptors in experimental hepatic encephalopathy. Life Sci. 1983 Mar 28;32(13):1417-25. PubMed PMID: 6403789.
5: Laven R, Schäfer EA. [Release of norfenefrine from sustained-release formulations by an in vitro dissolution model. Simulation of "drug levels" by calculation using pharmacokinetical constants and comparison with in vivo course of action (author's transl)]. Arzneimittelforschung. 1981;31(2):353-6. German. PubMed PMID: 7194653.
6: HEINECKER R, NANAY I. [ON THE EFFECT OF MONOAMINE OXIDASE INHIBITORS (MAOI) ON THE EFFECT OF ORALLY ADMINISTERED M-HYDROXY-1-PHENYL-2-AMINOETHANOL HCL (NOVADRAL) ON THE BLOOD CIRCULATION]. Arch Kreislaufforsch. 1963 Dec;42:63-84. German. PubMed PMID: 14116199.
